Hormone Receptor Negative Neoplasm

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2021-05-19
Clinical Trial Update: Effect of Pembrolizumab (Keytruda®) on Biomarkers in Early Breast Cancer. [EARLY_Phase 1]
A Phase 1 trial evaluating pembrolizumab (Keytruda) effects on biomarkers in early breast cancer, including triple-negative and hormone rece…